W A Macdonald

Engineering · Physical Sciences

23h-index2.7kcitations135works45.22yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Traffic and Road Safety(25), Human-Automation Interaction and Safety(11), Safety Warnings and Signage(11), Ion channel regulation and function(10), Muscle activation and electromyography studies(10)

Publications132 total

Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial
The Lancet Oncology·2025· 39 cited
Staining patterns of aldosterone synthase in patients undergoing surgery for primary aldosteronism: Proposal for system of categorization and investigation of clinical and biochemical correlation
Surgery·2024· 5 cited
Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study
The Lancet Oncology·2024· 86 cited
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
The Lancet Oncology·2024· 126 cited
Grow-light smart monitoring system leveraging lightweight deep learning for plant disease classification
Artificial Intelligence in Agriculture·2024· 15 citedOpen Access
Physicians and their Financial Futures with William L. MacDonald
2024
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
The Lancet Oncology·2023· 172 cited
Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) and capecitabine plus temozolomide (CAPTEM) for pancreas and midgut neuroendocrine tumours (pNETS, mNETS)—Final results.
Journal of Clinical Oncology·2022· 28 cited
Technetium‐99 m‐sestamibi single‐photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses
British Journal of Urology·2022· 13 cited
Chloride channel inhibition improves neuromuscular function under conditions mimicking neuromuscular disorders
Acta Physiologica·2021· 23 cited
Long-term survival and toxicity in patients with progressive advanced neuroendocrine tumors treated with lutetium peptide radiolabelled radiotherapy: A Western Australian long-term follow-up study.
Journal of Clinical Oncology·2021· 2 cited
177Lu-PSMA-617 versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer: a randomised, open-label, phase 2 trial (TheraP)
2021
The effect of Vitamin-K1 and Colchicine on Vascular Calcification Activity in subjects with Diabetes Mellitus (ViKCoVaC): A double-blind 2x2 factorial randomized controlled trial
Journal of Nuclear Cardiology·2021· 24 citedOpen Access
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
The Lancet·2021· 1.0k cited
Providing AC2Tionable Feedback Improves Resident and Fellow Satisfaction
2021
ABSTRACTS FROM THE INTERNATIONAL UNDERGRADUATE MEDICAL RESEARCH CONFERENCE 2021 (OPC)
International e-Journal of Science Medicine & Education·2021Open Access
Thoracic endometriosis presenting as recurrent pleural effusions
Radiology Case Reports·2020· 5 citedOpen Access
Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours
Oncotarget·2020· 19 citedOpen Access
Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: Phase II study evaluating the activity of <sup>177</sup>Lu-Octreotate peptide receptor radionuclide therapy (LuTate PRRT) and capecitabine, temozolomide CAPTEM)—First results for pancreas and updated midgut neuroendocrine tumors (pNETS, mNETS).
Journal of Clinical Oncology·2020· 26 cited
Might Nature Be Canadian?
McGill-Queen's University Press eBooks·2020· 1 cited
page 1 of 7Next →

Frequent Co-authors

David A. Pattison(9), Roslyn J. Francis(7), Michael S. Hofman(6), Louise Emmett(6), Anthony M. Joshua(6), Ian Kirkwood(6), Siobhan Ng(6), Andrew Weickhardt(6), Sze-Ting Lee(6), Andrew Redfern(6), Peter Lin(6), D. George Stephenson(6), Ole Bækgaard Nielsen(6), Shahneen Sandhu(5), Thean Hsiang Tan(5), Craig Gedye(5), Natalie Rutherford(5), Shakher Ramdave(5), Wei Chua(5), Martin R. Stockler(5)